secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionik Laboratories Corp. (—)
CIK:        0001508381
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001104659-23-072286
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionik explores 'going dark', cost-cutting; launches up to $2M debt offering
----------------------------------------------------------------------------

- Private offering of convertible notes up to $2M; initial $220k from Chairman affiliate Andre-Jacques Auberton-Herve.
- Directors convert $108,333 each in accrued fees into promissory notes with 1% monthly interest.
- Exploring cost-cutting including possible 'going dark' by suspending SEC filings, reducing board, headcount, and facility space.
- Outstanding notes converted into 4,083,544 shares; 3.1M shares to director affiliate.
- Company considers sale or restructuring; net proceeds from offering for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1508381/000110465923072286/0001104659-23-072286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1508381/000110465923072286/tm2318913d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer